DISSOLUTION AGREEMENT
This Dissolution Agreement (this “Agreement”) is entered into as of March 6,
2017 (the “Effective Date”), by and between AutoMD, Inc., a Delaware corporation
(“AutoMD”), with an address of 16941 Keegan Avenue, Carson, California 90746,
Oak Investment Partners XI, Limited Partnership (“Oak”), with an address of 525
University Avenue, Suite 1300, Palo Alto, CA 94301, and Sol Khazani Living Trust
(the “Khazani Trust” and together with USAP and Oak, the “AutoMD Stockholders”),
with an address of 578 Washington Blvd., #854, Marina Del Rey, CA 90292. AutoMD
and the AutoMD Stockholders shall together be referred to herein as the
“Parties”, and each may be referred to herein as a “Party”.
WHEREAS, the Board of Directors of AutoMD and the AutoMD Stockholders have
evaluated various business and strategic options with respect to AutoMD, and
following such evaluation, have determined that it is in the best interests of
the AutoMD Stockholders to dissolve AutoMD.
WHEREAS, Oak and the Khazani Trust (the together, the “Sellers”) would have
certain preferential stockholder rights upon a dissolution of the Company as set
forth under the AutoMD Financing Documents (as defined below), and in
consideration of the Redemptions (as defined below), the Parties agree to
terminate the AutoMD Financing Documents pursuant to the terms of this
Agreement.
WHEREAS, prior to a dissolution of AutoMD, the Board of Directors of AutoMD and
the AutoMD Stockholders deem it to be in the best interests of AutoMD to effect
a redemption of the 1,500,000 shares of AutoMD common stock owned by Oak (the
“Oak Shares”) and the 500,000 shares o AutoMD common stock owned by the Khazani
Trust (the “Khazani Trust Shares, and together with the Oak Shares, the
“Shares”) and to settle and compromise fully and finally any and all disputes,
controversies, entitlements, and claims that the Sellers may have against AutoMD
and its parent company, U.S. Auto Parts Network, Inc. (“USAP”), and their
respective directors and officers, on the terms and conditions set forth herein.
NOW, THEREFORE, in consideration of the promises, covenants, and agreements
contained herein, the Parties agree as follows:
1. Redemption.
1.1    Redemptions. Subject to the terms and conditions set forth in this
Agreement, the Sellers agree to sell to AutoMD, and AutoMD agrees to purchase
and redeem from the Sellers all of their respective shares (the “Shares”) of
AutoMD common stock (the “Redemptions”):
1.2    Closing.
(a) The closing of the Redemptions (the “Closing”) shall be effective as of the
Effective Date.
(b) At Closing, each Seller shall deliver to AutoMD their respective share
certificate evidencing the Shares, together with a stock power executed in
blank; and
(c) At Closing, AutoMD shall deliver to Oak the sum of $895,500 by wire transfer
of immediately available funds to an account or accounts designated by Oak.
(d) At Closing, AutoMD shall deliver to the Khazani Trust the sum of $298,500 by
wire transfer of immediately available funds to an account or accounts
designated by the Khazani Trust.
1.3    Termination of Obligations under Existing Agreements. From and after the
Closing, except as otherwise set forth in this Agreement or any agreement,
instrument, or document executed in connection herewith or delivered at Closing,
all of the Parties’ obligations (whether accrued or contingent) to each other
under all agreements between each Seller, on the one hand, and USAP and/or
AutoMD, on the other hand, shall cease and be of no further force and effect and
such agreements shall be deemed terminated and of no further force or effect,
including without limitation, the following agreements and the Parties’
obligations thereunder: (a) the Investor Rights Agreement, dated October 8,
2014, by and among AutoMD and the investors named therein, (b) the Voting
Agreement, dated October 8, 2014, by and among AutoMD and the investors named
therein, (c) the Right of First Refusal Agreement and Co-Sale Agreement, dated
October 8, 2014, by and among AutoMD and the investors named therein, and (d)
the Common Stock Purchase Agreement, dated October 8, 2014, by and among AutoMD
and the investors named therein (collectively, the “AutoMD Financing
Documents”).

--------------------------------------------------------------------------------

2. Release.
2.1    Seller Release.
(a)    Each Seller hereby acknowledges that, in consideration for its respective
Redemption and other valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, from and after the Closing, such Seller, on
behalf of itself and its respective subsidiaries, parents, affiliates, agents,
legal representatives, predecessors, succesors and assigns (collectively, the
“Other Releasing Parties”) hereby fully, finally, and completely releases each
of AutoMD, USAP and their respective subsidiaries, affiliates, stockholders,
officers, directors, employees, agents, attorneys, representatives and
representatives of each of them (the “Released Parties”), of and from any and
all claims, actions, demands, and/or causes of action, of whatever kind or
character, whether now known or unknown, arising from, relating to, or in any
way connected with such Seller’s investment in AutoMD, Seller’s rights as a
stockholder of AutoMD, Seller’s rights under the AutoMD Financing Documents,
and/or any other facts or events occurring on or before the Closing; provided,
however, that such Seller is not releasing any claims for (a) breach of any
representation, warranty, covenant or agreement of this Agreement or any
agreement, instrument, or document executed or delivered in connection with the
Closing by any Released Parties, or (b) any director indemnification obligations
owed by any Released Party pursuant to AutoMD’s or USAP’s certificate of
incorporation or bylaws or any director indemnification agreement.  Each Seller,
on behalf of itself and the Other Releasing Parties, agree that this Agreement
includes a release of any negligence claims, contractual claims for breach or
default, and any claims for any alleged breach of fiduciary duties owed by
AutoMD, USAP, or any of the other Released Parties in any capacity, and any
related attorneys’ fees and costs, if any, that such Seller or any of the Other
Releasing Parties may have against AutoMD, USAP, or any of the other Released
Parties. Each Seller, on behalf of itself and the Other Releasing Parties,
waives and releases the Released Parties from each and every claim that this
Agreement was procured by fraud or signed under duress or coercion so as to make
this release not binding. Each Seller, on behalf of itself and the Other
Releasing Parties, understands and agrees that by signing this Agreement it is
giving up the right to pursue legal claims that it may have against any of the
Released Parties.
(b)    The release set forth in this Section 2.1 is intended as a release of all
claims against the Released Parties, whether now known or unknown. In
furtherance thereof, each Seller, on behalf of itself and the Other Releasing
Parties, expressly waives any right or claim of right to assert hereafter that
any claim, demand, obligation and/or cause of action has, through ignorance,
oversight, error or otherwise, been omitted from the terms of this Agreement. 
Each Seller, on behalf of itself and the Other Releasing Parties, make this
waiver with full knowledge of its rights, after consulting with legal counsel,
and with specific intent to release both their known and unknown claims.
(c)    Each Seller hereby represents and warrants that neither it nor any Other
Releasing Party has assigned or otherwise transferred to any other person or
entity any interest in any claim, action, demand and/or cause of action it has,
or may have, or may claim to have in connection with the matters released hereby
and/or the persons and entities released herein, and hereby agrees to indemnify
and hold harmless the Released Parties from any and all injuries, harm, damages,
penalties, costs, losses, expenses and/or liability or other detriment including
all reasonable attorneys’ fees incurred as a result of any and all claims,
actions, demands, and/or causes of action of whatever nature or character that
may hereafter be asserted against any of the Released Parties by any person or
entity claiming by, through or under such Seller or any Other Releasing Party by
virtue of such an assignment or other transfer.
(d)    In furtherance of such Seller’s intent to waive and release any and all
claims against the Released Parties, on behalf of itself and the Other Releasing
Parties, whether or not now known to such Seller, each Seller also expressly
waives and releases, on behalf of itself and the Other Releasing Parties, any
and all rights and benefits under Section 1542 of the Civil Code of the State of
California, which reads as follows:
A general release does not extend to claims which the creditor does not know or
suspect to exist in his favor at the time of executing the release, which if
known by him, must have materially affected his settlement with the debtor.
Each Seller, on behalf of itself and the Other Releasing Parties, acknowledge
that it understands that this provision means that, if it later discover facts
different from, or facts in addition to, those facts currently known by them, or
believed by them to be true, the waivers and releases of this Agreement will
remain effective in all respects-despite such different or additional facts and
such Seller’s or any Other Releasing Party’s later discovery of such facts, and
even if they would not have agreed to these waivers and releases if they had
prior knowledge of such facts.
3. Representations and Warranties of Seller. Each Seller represents and warrants
to AutoMD as follows:

--------------------------------------------------------------------------------

3.1 Ownership.  Such Seller owns the Shares beneficially and of record free and
clear of all liens, claims, encumbrances, proxies and restrictions of any kind
or nature whatsoever and will convey to AutoMD valid and marketable title to its
respective Shares.  There are no outstanding options, warrants, subscriptions or
other rights or obligations to purchase or acquire any of its respective Shares
issued, created or otherwise made effective by such Seller, nor any outstanding
securities convertible into or exchangeable for any of its respective Shares
issued, created or otherwise made effective by such Seller.
3.2 Authority.  Upon the execution and delivery by such Seller of this Agreement
and the other agreements contemplated hereby, this Agreement and the other
agreements contemplated hereby will constitute the legal, valid, and binding
obligations of such Seller.  Such Seller has the right, power, and authority to
execute and deliver this Agreement and to perform its obligations under this
Agreement and the other agreements contemplated hereby. Such Seller is not, nor
will it be, required to obtain any consent from any person in connection with
the execution and delivery of this Agreement and the other agreements
contemplated hereby, the consummation or performance of any of the transactions
contemplated hereby or thereby, or the sale and delivery of its respective
Shares (other than consents obtained prior to, and in full force and effect as
of, the Effective Date).
3.3 Investment Representations.

(a) Such Seller is capable of evaluating and bearing the risks and merits of
selling its respective Shares for the respective redemption price set forth
above and pursuant to the terms of this Agreement.
(b) Such Seller has had, during the course of this transaction and prior hereto,
the opportunity to ask questions of, and receive answers from, AutoMD and its
management concerning AutoMD, its operations and prospects, and the terms and
conditions of this Agreement.
(c) Such Seller believes that it has received all such information as it
considers necessary for evaluating the risks and merits of selling the Shares
for the redemption price and pursuant to the terms of this Agreement and for
verifying the accuracy of any information furnished to it or to which it had
access.
(d) Neither AutoMD, nor USAP, nor any of the other Released Parties has made any
representations or warranties, express or implied, regarding AutoMD, its
management, operations and prospects, the value of the Shares or otherwise
regarding any aspect of the transaction except as set forth in Section 4 of this
Agreement, and such Seller is not relying on any such representation or warranty
not contained in Section 4 of this Agreement, and shall have no claim or right
against either AutoMD or USAP or any of their respective Released Parties with
respect to any information, documents or materials furnished by either AutoMD or
USAP or any of their respective Released Parties to such Seller or any of its
respective affiliates, employees, attorneys, advisors or representatives in any
data room, presentation, interview or in any other form or manner relating to
the transactions contemplated hereby.
3.4    Acceptance of Risk. Each Seller, on behalf of itself and the Other
Releasing Parties, is entering into this Agreement freely and understand and
expressly accept and assume the economic and market risk associated with such
Seller selling its respective Shares for the respective redemption price set
forth above (including that such redemption price may be less than the fair
market value of the Shares or less than the price that the Shares might have
been sold for in an alternative transaction), agree that this Agreement shall be
in all respects effective and not subject to termination or rescission under any
circumstances, and agree, on behalf of themselves and the other Releasing
Parties, that they shall have no claim or right against AutoMD, USAP or any of
the other Released Parties based on such redemption price being less than the
fair market value of the Shares or less then the price that the Shares might
have been sold for in an alternative transaction.

3.5    Tax Consequences. Each Seller acknowledges that AutoMD is making no
representation or warranty as to the tax consequences for such Seller in selling
its respective Shares for the respective redemption price pursuant to this
Agreement. Each Seller further acknowledges that it has had an opportunity to
seek independent counsel and advisors with respect to tax and other matters
relating to this Agreement, that it shall bear the full tax consequences, if
any, of selling its respective Shares for the redemption price set forth above
and pursuant to the terms of this Agreement in all circumstances.

3.6    Indemnification Covenant. Each Seller is aware that AutoMD is relying
upon the truth of the foregoing representations, warranties and covenants in
this Section 3 in connection with entering into this Agreement and the
transactions contemplated by this Agreement. Each Seller shall indemnify,
protect, defend and hold free and harmless AutoMD and USAP from and against all
losses resulting from the defense, settlement or compromise of a claim or demand
or assessment incurred by them as a result of any breach by such Seller of any
of its representations, warranties or covenants contained in this Agreement.

4. Representations and Warranties of the Company.  AutoMD represents and
warrants to Seller as follows:

--------------------------------------------------------------------------------

4.1 Capital Structure.  AutoMD’s authorized capital stock (immediately prior to
Closing) is 23,450,000 shares of common stock, of which 16,500,000 shares are
currently issued and outstanding. In addition, there are 1,405,000 options to
purchase shares of common stock outstanding. The 16,500,000 outstanding shares
of common stock together with the 1,405,000 options represent all of the
outstanding equity interests in AutoMD.  There are no outstanding or authorized
options, warrants, purchase rights, subscription rights, conversion rights,
exchange rights or other contracts or commitments that require AutoMD to issue,
sell or otherwise cause to become outstanding any of its capital stock, other
than those set forth in the AutoMD Financing Documents. There are no outstanding
stock appreciation, phantom stock or similar rights with respect to AutoMD.
AutoMD has no obligation of any kind to issue any additional equity interests in
AutoMD to any person.
4.2 Authority.  Upon the execution and delivery by AutoMD of this Agreement and
the other agreements contemplated hereby, this Agreement and the other
agreements contemplated hereby will constitute the legal, valid, and binding
obligations of AutoMD. AutoMD has the right, power, and authority to execute and
deliver this Agreement and the other agreements contemplated hereby and to
perform its obligations under this Agreement and the other agreements
contemplated hereby. Other than consents obtained prior to, and in full force
and effect as of, the Effective Date, AutoMD is not, nor will be, required to
obtain any consent from any person in connection with the execution and delivery
of this Agreement and the other agreements contemplated hereby, the consummation
or performance of any of the transactions contemplated hereby or thereby, or the
Redemptions.
5. Choice of Law.  This Agreement shall be governed by and construed under the
laws of the State of Delaware in all respects as such laws are applied to
agreements among Delaware residents entered into and performed entirely within
Delaware, without giving effect to conflict of law principles thereof. The
parties agree that any action brought by any Party under or in relation to this
Agreement, including without limitation to interpret or enforce any provision of
this Agreement, shall be brought in, and each Party agrees to and does hereby
submit to the jurisdiction and venue of, any state or federal court located in
the State of Delaware.
6. Terms Confidential.  The Parties shall keep the terms, amounts and facts of
this Agreement completely confidential to avoid disclosure hereafter of any
information concerning this Agreement to anyone except their respective
attorneys, accountants, or other professional advisors.  Notwithstanding the
foregoing prohibition, (a) the Parties shall not be prohibited from disclosing
the terms, amounts and facts of this Agreement or this Agreement itself as may
be requested by governmental entities or as may be required by law, including
any Federal or state securities laws or regulations, (b) AutoMD shall not be
prohibited from disclosing the terms, amounts and facts of this Agreement or
this Agreement itself as may be requested by any person or entity with whom
AutoMD is engaged in discussions with concerning any investment in AutoMD or any
financing, recapitalization, reorganization, or sale of the capital stock of
AutoMD (or any rights thereto) or all or substantially all of the assets of
AutoMD and (c) USAP shall not be prohibited from disclosing the terms, amounts
and facts of this Agreement or this Agreement itself as may be requested by any
person or entity with whom USAP is engaged in discussions with concerning any
investment in USAP or any financing, recapitalization, reorganization, or sale
of the capital stock of AutoMD (or any rights thereto) or all or substantially
all of the assets of USAP.
7. Entire Agreement.  This Agreement, and the other agreements, instruments, or
documents executed in connection herewith or delivered at Closing, constitute
the entire agreement among the parties with respect to the subject matter hereof
and thereof, and supersede any other agreement with respect hereto and thereto,
and there are no other or continuing agreements or understandings between each
Seller, on one hand, and AutoMD and/or USAP, on the other hand, except as
expressly recited herein or therein.
8. Execution in Counterparts.  This Agreement may be executed in any number of
counterparts, each of which when so executed and delivered shall constitute an
original, but such counterparts together shall constitute but one and the same
Agreement.  The exchange of copies of this Agreement and of signature pages by
facsimile transmission or PDF shall constitute effective execution and delivery
of this Agreement as to the Parties and may be used in lieu of the original
Agreement for all purposes.  Signatures of the Parties transmitted by facsimile
or PDF shall be deemed to be their original signatures for all purposes.
9. Legal Advice.  Each Party hereto acknowledges that such Party has had the
advice of independent counsel selected by such Party in connection with the
terms of this Agreement and the other agreements executed in connection
herewith, and that no offer, promise, inducement or consideration of any kind or
degree, except as expressly stated in this Agreement, has been provided or
promised to such Party by any other Party or person in connection with such
Party’s entry into this Agreement and the other agreements executed in
connection herewith.
10. Severability.  Should any provision of this Agreement be declared and/or be
determined by any court to be illegal or invalid, the validity of the remaining
parts, terms or provisions shall not be affected thereby.
11. Expenses.  Except as otherwise provided in this Agreement, each Party to
this Agreement will bear its respective fees and expenses incurred in connection
with the preparation, negotiation, execution and performance of this Agreement
and the transactions

--------------------------------------------------------------------------------

contemplated by this Agreement, including all fees and expenses of its agents
and representatives.  If any Party hereto institutes a proceeding to enforce
such Party’s rights in accordance with the provisions of this Agreement, the
prevailing Party shall be entitled to recover its reasonable expenses, including
attorneys’ fees, in connection with any such action.
12. Further Assurances.  At any time and from time to time, upon the reasonable
request of a Party hereto, each other Party hereto shall promptly execute and
deliver all such further agreements, documents, and instruments and take such
further action as may be necessary or appropriate to carry out the provisions
and purposes of this Agreement or any other agreement executed in connection
herewith.
13. Miscellaneous.  This Agreement shall be binding upon, and inure to the
benefit of the Parties hereto and their respective heirs, successors and
assigns. A modification or waiver of any of the provisions of this Agreement
shall be effective only if made in writing and signed by each of the Parties
hereto.  The failure of any Party to insist upon the strict performance of any
of the provisions of this Agreement shall not be construed as a waiver of any
subsequent default of the same or any other provision.
14. Notices.  Any notices required to be given pursuant to the provisions hereof
shall be given in writing to the parties below by certified mail, return receipt
requested, as follows:
If to AutoMD:
AutoMD, Inc.
16941 Keegan Avenue
Carson, California 90746
Attention: General Counsel

If to Oak:
 
Oak Investment Partners XI, Limited Partnership
525 University Avenue, Suite 1300
Palo Alto, CA 94301
Attention: Fred Harman and Craig Lang

If to the Khazani Trust:

Sol Khazani Living Trust
578 Washington Blvd., #854
Marina Del Rey, CA 90292
Attention: Sol Khazani

15. Third Party Beneficiary.  For avoidance of doubt, USAP and the other
Released Parties are third party beneficiaries under this Agreement and shall be
entitled to the rights and benefits hereunder and may enforce the provisions
hereof as if they were parties hereto.

[SIGNATURE PAGE FOLLOWS]
 

--------------------------------------------------------------------------------

IN WITNESS WHEREOF, the undersigned have caused this Agreement to be executed
and entered into as of the day and year first above written.
AutoMD, Inc.
 
 
 
By:
/s/ Shane Evangelist
 
Name: Shane Evangelist
Title: Chief Executive Officer
 
 
 
 

Oak Investment Partners XI, Limited Partnership

By: Oak Associates XI, LLC, its General Partner
 
 
 
By:
/s/ Fred Harman
 
Name: Fred Harman
 
Title: Managing Member
 
 

 
Sol Khazani Living Trust
 
 
 
By:
/s/ Sol Khazani
 
Name: Sol Khazani
Titles: Authorized Signatory